Environmental, Social And Governance Report

Overview

The report covers Hua Medicine and its subsidiaries for 2022, with disclosures on environmental management, employees, responsible operations and community engagement. The company highlights approval and first prescription sale of HuaTangNing, its first-in-class glucokinase activator, and continued commercialization and R&D progress. It reports a Board-led ESG governance structure supported by senior management and the EHS department, alongside quantified Scope 1 and Scope 2 emissions, resource use and workforce data. The report also describes strengthened product quality, anti-corruption and supplier-management systems.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services